Final days for early bird for AusBiotech 2012

The AusBiotech national conference attracts over 1,100 delegates from across the world annually with its agenda-setting program, which will this year feature an impressive array of more than 150 local and overseas presenters, including the annual Millis Oration by Dr Alan Robertson, CEO of Pharmaxis and a plenary address by renowned thought leader in healthcare, Dr Richard Barker, Director of Celgene (USA).

Dr Richard Barker, well known to many as the former director general of the Association of the British Pharmaceutical Industry (ABPI), who served on the Board and Executive Committee of the European Federation of Pharmaceutical Industries and Associations and as a Council Member of the International Federation of Pharmaceutical Manufacturers & Associations, has been recently elected to the board of directors at Celgene.

Prior to his post leading the ABPI, Barker’s career included serving as chief executive of Chiron Diagnostics, general manager of IBM’s Worldwide Healthcare Solutions division and leader of McKinsey & Company’s European healthcare practice.

Robert Hugin, Celgene’s chairman and CEO, said: “As we continue to expand our global reach, Dr Barker’s international perspective will enhance our ability to navigate through an increasingly dynamic healthcare landscape and provide patients access to our innovative therapies.”

AusBiotech delegates will hear Dr Barker’s valuable insights on the role of biotechs in the drug development universe as well as opportunities for early commercialisation of medical innovation through partnerships of difference, leveraging his unique perspective on international markets.

Early bird registration saves you $250 and closes on 30 June 2012. For further information or to register, visit www.ausbiotechnc.org.